跳到主要內容

臺灣博碩士論文加值系統

(44.192.254.173) 您好!臺灣時間:2023/10/02 06:25
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:林宗瑤
研究生(外文):Tsung-Yao Lin
論文名稱:內毒素與薑黃素對大腸癌細胞(Caco-2)的影響
論文名稱(外文):Effects of LPS and curcumin on Caco-2 cells.
指導教授:馬明琪
指導教授(外文):Ming-Chei Maa
學位類別:碩士
校院名稱:中山醫學大學
系所名稱:生物化學研究所
學門:生命科學學門
學類:生物化學學類
論文種類:學術論文
論文出版年:2002
畢業學年度:90
語文別:中文
論文頁數:81
中文關鍵詞:內毒素薑黃素大腸癌細胞
外文關鍵詞:LPScurcumincolorectal carcinoma cellc-Src
相關次數:
  • 被引用被引用:7
  • 點閱點閱:812
  • 評分評分:
  • 下載下載:173
  • 收藏至我的研究室書目清單書目收藏:2
Lipopolysaccharides (LPS;內毒素)為格蘭氏陰性菌細胞壁中的成份之一。當人體免疫力下降或手術未癒之病人受到格蘭氏陰性菌嚴重感染時,細菌的LPS會經由血液侵犯人體,引發發燒、敗血性休克,甚至是器官衰竭等症狀。由於腸道組織為格蘭氏陰性菌的大本營,因此我們想探討LPS對其可能產生的生理反應。在我們的研究中,我們發現10 μg/ml LPS會刺激大腸癌上皮細胞 (Caco-2)的生長速率與移動能力。進一步探討其分子機轉,我們觀察到LPS會增加c-Src蛋白表現,進而使其下游蛋白,Shc與Erk的tyrosyl phosphorylation增加,促進細胞生長。此外,另一個Src的受質,FAK,其tyrosyl phosphorylation也因LPS促進Src整體活性提高而增加,而這可能與細胞的移動有關。RT-PCR的實驗結果指出,LPS促進c-Src蛋白量的增加與其mRNA的增加有關。
薑黃素 (curcumin)是一種薑科植物Curcuma longa地下莖,所萃取出來的黃色色素,具有抗發炎、抗氧化,以及抗癌的效果。由於其為食用色素,我們想了解其能否抑制大腸直腸癌並探討其分子機轉。因此,我們選用了一株大腸癌細胞 (Caco-2),做為實驗材料。從我們的實驗結果,我們發現curcumin會抑制癌細胞的生長;同時我們也觀察到一個有趣的現象,那就是curcumin會減弱癌細胞metastasis的能力。當Caco-2細胞以不同濃度的curcumin處理時,細胞總體蛋白的酪胺酸磷酸化程度會明顯下降。而此與c-Src蛋白表現隨著curcumin濃度的增加而遞減相關。另外讓我們感到有趣的是,FAK,一個在integrin signaling pathway上重要的調節蛋白,它的autophosphorylation state竟也會隨著curcumin濃度的增加而下降。綜合以上的結果,我們推測curcumin造成c-Src蛋白表現與活性降低以及FAK蛋白的活性下降,或許與其抗癌與減緩癌細胞轉移的能力有關。

Lipopolysaccharides (LPS;endotoxin) are cell wall components of most gram-negative bacteria. During sereve bacterial infections, as occurred in post-operation or immune suppressed patients, large amounts of LPS may be released into the blood stream and leads to various pathophysiological reactions such as fever, septic shock, and multi-organ failure. Since GI tract is the tissue that exposed to LPS most, we are interested to study its effect on colon epithelial cells. In the study, we observed that 10 μg/ml LPS can enhance the growth rate of Caco-2 cells (colorectal adeno- carcinoma cells), and improve their metastatic ability to migrate on dish coated with collagen. Furthermore, we found that LPS could upregulate the expression of c-Src protein that in turn caused the enhancement of tyrosyl phosphorylation of Shc and ERK and promoted cellular growth. In addition, LPS induced FAK Tyr-397 phosphorylation might attribute to cell mobility.
Curcumin, an active yellow pigment of Curcuma longa, possesses anti-inflammatory, antioxidative and anticarcinogenic properties. To delineate its antitumorigenic mechanisms, the colorectal adenocarcinoma cell line, Caco-2, was utilized as the material in our study. Like what has been described in other cells, significant growth inhibition of Caco-2 was detected in the presence of curcumin. At the same time, we also found that curcumin could reduce the metastasis ability of Caco-2 cells. And when the profile of tyrosyl phosphorylated proteins was analyzed, significant reduction of overall tyrosyl phosphorylation was observed in curcumin -treated cells as compared to that in control. Surprisingly, suppression of c-Src expression in response to curcumin was observed while no change of the expression level of actin was detected. The curcumin-mediated reduction of c-Src expression resulted in the aborgation of c-Src activity as evidenced by reduced tyrosyl phosphorylation of cortactin, a Src substrate. Interestingly, accompanying with downregulation of c-Src in curcumin-treated cells was the reduced tyrosyl phosphorylation and the enzymatic activity of FAK, an important player in integrin signaling. With these findings, we suggested that curcumin-mediated reduction of the expression and activity of c-Src might attribute to curcumin-mediated anticarcinogenic effects.

中文摘要 ……………………………………………………………… 1
英文摘要 …………………………………………………………….... 3
縮寫檢索表 …………………………………………………………… 5
第一章 序論 …………………………………………………………...7
第二章 實驗材料與方法 …………………………………………… 15
第三章 結果 ……………………………………………………….. ..35
第四章 討論 ……………………………………………………….....45
參考文獻 ……………………………………………………………...50
圖表 …………………………………………………………………...59

Akio T, Carol PG, Richard RA, Stephen KA, Hsing-Jien K, and Donald JF. (1987) DNA sequence encoding the amino-terminal region of the human c-src protein : implications of sequence divergence among src-type kinase oncogenes. Mol Cell Biol. 7, 1978- 1983.
Amphawan A, Nongnuch V, and Duang B. (1995) Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethno- pharmacology. 49, 163-169.
Andrew EA, Alan KH , and RL J. (1999) Cell adhesion molecules, signal transduction and cell growth. Current Opinion Cell Biol. 11,737—744.
Anja S, Emmanuelle C, and Allan H. (2001) Lipopolysaccharide-induced activation of β2-integrin function in macrophages requires Irak kinase activity, p38 mitogen-activated protein kinase, and the Rap1 GTPase. Mol Cell Biol. 21, 438-448.
Anna R, Kira S, Elena M, Ernst-Dietrich K, Armand T, and Alexander T. (1999) Phosphorylation of p125FAK and paxillin focal adhesion proteins in src-transformed cells with different metastatic capacity. FEBS Lett. 455, 145-148.
Anoop KS, Gurmel SS, Deepa T, and Radha KM. (1996) Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. Cancer Lett. 107, 109-115.
Aplin AE, Howe A, Alahari SK, and Juliano RL. (1998) Signal transduction and signal modulation by cell adhesion receptors : the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Therapeut. 50, 197-263.
Cai H, Jiali L, Christian CH, and Xi Z. (1998) The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Boil Chem. 273, 25770-25776.
Carla JC. (1999) New insights into the role of serum amyloid P component, a novel lipopolysaccharide-binding protein. FEMS Immunol Med Mic. 26, 197-202.
Christian J, Cynthia AB, Maria PR, Booker J, Acharan SN, David AB, and Balfour S. (1999) Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-kB kinase activity. The J Immuno. 163, 3474-3483.
Christof RH, Datsun AH, and David DS. (2000) Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J Boil Chem. 275, 41092-41099.
Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, and Cheng AL. (2000) Curcumin-containing diet inhibits diethyl- nitrosamine induced murine hepatocarcinogenesis. Carcinogenesis 21, 331-335.
Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS, Laskin JD, and Huang MT. (1991) Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul. 31, 385-389.
Cross FR, Garber EA, and Hanafusa H. (1985) N-terminal deletions in rous sarcoma virus p60Src : effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene. Mol Cell Biol. 5, 2789-2795.
Huang MT, Lou YR, Ma W, Newmark LH, Reuhl KR and Conney AH. (1994) Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 54, 5841—5847.
Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, and Conney AH. (1991) Inhibitory effects of curcumin in vivo lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51,813-819.
Huang MT, Ma W, Lu YP, Chang RL, Fischer C, Manchand PS, Newmark HL, and Conney AH. (1995) Effect of curcumin, demethoxycurcumin, bisdemethoxy-curcumin and tetrahydrocurcumin on TPA-induced tumor promotion. Carcinogenesis 16, 2493-2497.
Huang MT, Smart RC, Wong CQ, and Conney AH. (1988) Inhibitory
effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48, 5941-5946.
Huang MT, Wang ZY, Georgiadis CA, Laskin JD, and Conney AH.
(1992) Inhibitory effect of curcumin on tumor initiation by benzo [a]pyrene and 7,12-dimethyl-benz[a]anthracene. Carcinogenesis 13, 947-954.
Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T, and Aizawa S. (1995) Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544.
Jiang MC, Yang-Yen HF, Yen JJ, and Lin JK. (1996) Curcumin induces
apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer. 26, 111-120.
Jen-Kun L, and Shoei-Yn LS. (2001) Mechanisms of cancer chemoprevention by curcumin. Proc. Natl. Sci. Counc. ROC(B). 25, 59-66.
Jones RJ, Brunton VG, and Frame MC. (2000) Adhesion-linked kinases in cancer; emphasis on Src, focal adhesion kinase and PI 3-kinase. Eur J Cancer. 36, 1595-1606.
Keith S, Christopher MD, Matthew W, and Carolyn F. (1996) Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett. 103, 137-141
Klemke R, Leng J, Molander R, Brooks P, Vuori K, and Cheresh D. CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. (1998) J Cell Biol. 140, 961-972.
Knirel YA. (1990) Polysaccharide antigens of Pseudomonas aeruginosa. Crit Rev Microbiol. 17, 273-304.
Kodi SR. (2001) Signaling via Shc family adapter proteins. Oncogene 20, 6322-6330.
Kunchandy E, and Rao MNA. (1990) Oxygen radical scavenging activity
of curcumin. Int'l J Pharm. 38, 239-240
Lata GM, Ramadasan K, Girija K. (1999) Anti-metastatic activity of curcumin and catechin. Cancer Lett. 141, 159-165.
Lin JK, Chen YC, Huang YT, and Lin-Shiau SY. (1997) Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J Cell Biochem. 28/29, 39-48.
Luigina F, and Denise D. (1998) Nitric oxide enhances prostaglandin production in ethanol-induced gastric mucosal injury in rats. Euro J Pharmacology. 348, 247-256.
Lu YP, Chang RL, Lou YR, Huang MT, Newmark HL, Reuhl KR, and Conney AH. (1994) Effect of curcumin on 12-O-tetradecanoylphorbol- 13-acetate and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. Carcinogenesis 15, 2363-2370.
Lutz H, Volker EL-S, Artur JU, Hans-Dieter F, and Ernst TR. (1998) Components of gut bacteria as immunomodulators. Inter J Food Microbiology. 41, 141-154.
Marc DB, Irvin MM, and Joseph AM. (1992) Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J Clin Invest. 90, 15-23.
Marcia AW, Jeong HY, Leif EO, and Robert MW. (2001) Cyclooxygenase-2 protein and prostaglandin E2 production are up-regulated in a rat bladder inflammation model. Euro J Pharmacology. 417, 239-248.
Margaret MM, Andreas G,Hudson EA, Simon MP, Matthew SS, and Sally AP. (2000) Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicology Lett. 112—113, 499—505.
Mary TC, Stacey LH, and Anthony LD. (1996) Activation-induced association of a 145-kDa tyrosine-phosphorylated protein with Shc and Syk in B lymphocytes and macrophages. J Boil Chem. 270, 6824-6829.
Masayuki K, Takashi M, Kenji I, Akihiko U, Yasuo M, Mitsuo K, and Masao T. (2000) Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activation. Oncogene 19, 1225-1231.
Mazumder A, Raghavan K, Weinstein J, Kohn KW, and Pommier Y. (1995) Inhibition of HIV-1 integrase by curcumin. Biochem Pharm. 49, 1165-1170.
McMahon SB, and Monroe J. (1996) The role of early growth response gene-1 (egr-1) in regulation of the immune response. J Leukoc Biol. 60, 159—66.
Megan TB, and Jonathan AC. (1996) Regulation, substrates and functions of src. BBA. 1287,121-149.
Michael DS. (2001) Biochemical signals and biological responses elicited by the focal adhesion kinase. BBA. 1540, 1-21.
Michael JW. (2001) Colon cancer chemoprevention with ginseng and other botanicals. J Korean Med Sci. 16, S81-S86.
Min-Hsiung P, Shoei-Yn LS and Jen-Kun L. (2000) Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IκB Kinase and NFκB activation in Macrophages. Biochem Pharmacol. 60, 1665—1676.
Mushtaq A, Pandora T, and Russell MM. (1998) Role of activating Protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-α. J Biol Chem. 267, 16323-16329.
Otto H, Artur JU, Helmut B, Hans-Dieter F, Ernst TR. (1996) Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med Mic. 16, 83-104.
Peter BJ, and Tony H. (2001) Oncogenic kinase signaling. Nature 411, 355- 365.
Rajeshwari M, Susan LS, Ya L, and Salman A. (2001) Impaired activation of AP-1 and altered expression of constituent proteins in rat adrenal during ageing. Mech Ageing Dev. 122, 1169-1186.
Rao CV, Rivenson A, Simi B and Reddy BS. (1995) Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55, 259—266.
Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F, Schreier M, and Brade H. (1994) Bacterial endotoxin : molecular relationships of structure to activity and function. FASEB J. 218, 217-225.
Roberto M, Roberta F, Rekha B, and COLIN JG. (2000) Curcumin, an antioxidant and anti-inflammatory agent, indues heme oxyganase-1 and protects endothelial cells against oxidative stress. Free Radical Bio Med. 28, 1303—1312, 2000.
Rosenberg L, Louik C, and Shapiro S. (1998) Nonsteroidal anti- inflammatory drug use and reduced risk of large bowel carcinoma. Cancer 82, 2326-2333.
Ruby JA, Tessy TM, and Devarajan K. (2000) L-929 Cells harboring
ectopically expressed RelA resist curcumin-induced apoptosis. J Biol Chem. 275, 15601-15604.
Ruey-Long H, William HS, and Mien-Chie H. (1999) Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu1. Clin Cancer Res. 5, 1884-1891.
Sanjaya S, and Bharat BA. (1995) Activation of transcription factor NF-κB Is suppressed by curcumin (diferulolylmethane). J Biol Chem. 270, 24995- 25000.
Scott D, Mary-Anne S, and Keith B. (2001) SRC transcriptional activation in a subset of human colon cancer cell lines. FEBS Lett. 487, 367-371.
Shih CA, and Lin, JK. (1993) Inhibition of 8-hydroxydeoxyguanosine formation by curcumin in mouse fibroblast cells. Carcinogenesis 14, 709-712.
Stehelin D, Varmus HE, Bishop JM, and Vogt PK. (1976) DNA related to the transforming gene(s) of avian sarcoma virus is present in normal avian DNA. Nature (London) 260, 170-173.
Sui Z, Salto R, Li J, Craik C, and Ortiz de Montellano PR. (1993) Inhibition of HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem. 1, 415-422.
Tammy LK, and Frank B. (1995) CD14 and other recognition molecules for lipopolysaccharide : a review. Immunopharmacology 29, 187-205.
Tang-Long S, and Jun-Lin G. (2001) Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts. FEBS Lett. 499, 176-181.
Toshihiko K, Ronald L, Vernon ES, Gary JK, Robert BK, Chinthalapally V Rao, and Bandaru SR. (1999) Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/ progression stages of colon cancer. Cancer Res. 59, 597—601.
Toshiya M, Kayo H, Ayumi Shinohara, Tomomi Maekawa, Yoshio Takeda, and Hidemasa Y. (1999) Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcumin. J Agric Food Chem. 47, 71-77.
Usha RP, and Vijaya MR. (2000) Suppression of transcription factor Egr-1 by curcumin. Thrombosis Res. 97, 179-189.
Verde P, Boast S, Franze A, Robbiati F, and Blasi F. (1998) An upstream enhancer and a negative element in the 5’ flanking region of the human
urokinase plasminogen activator gene. Nucleic Acids Res. 16, 10699—716.
Wang LH, Halpern CC, Nadel M, and Hanafusa H. (1978) Recombination between viral and cellular sequences generates transforming sarcoma viruses. Proc Natl Acad Sci USA. 75, 5812-5816.
Wan-Jr S, Chien-Chang S, Ming-Jaw D, Jun-Chih O, Gene-Hsiang L, and Chang-Ming S. (1998) Cytotoxicity of curcuminoids and some novel compounds from Curcuma zedoaria. J Nat Prod. 61, 1531-1534.
Wargovich MJ, Chen CD, Harris C, Yang E, and Velasco M. (1995) Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int J Cancer. 60, 515-519.
Wargovich MJ, Jimenez A, McKee K, Steele VE, Velasco M, Woods J, Price R, Gray K, and Kelloff GJ. (2000) Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 21, 1149-1155.
Yan-Shi G, Mark RH, Xiao DW, and Courtney MT Jr. (2001) Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase -2 expression in intestinal epithelial cells. J Biol Chem. 276, 22941-22947.
Young-Joon S, Kyung-Soo C, Hyun-Ho C, Seong SH, Young-Sam K, Kwang-Kyun P,and Sang SL. (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down- regulation of COX-2 and iNOS through suppression of NF-κB activation.
Mutation Res. 480—481, 243—268.

QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top